OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anaplastic thyroid carcinoma: a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades
Mischa de Ridder, Els Nieveen van Dijkum, Anton F. Engelsman, et al.
European Journal of Endocrinology (2020) Vol. 183, Iss. 2, pp. 203-209
Open Access | Times Cited: 31
Mischa de Ridder, Els Nieveen van Dijkum, Anton F. Engelsman, et al.
European Journal of Endocrinology (2020) Vol. 183, Iss. 2, pp. 203-209
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Anaplastic Thyroid Carcinoma: An Update
Arnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1061-1061
Open Access | Times Cited: 89
Arnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1061-1061
Open Access | Times Cited: 89
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease
Inés Califano, Anabella Smulever, Fernando Jerkovich, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 25, Iss. 1, pp. 123-147
Closed Access | Times Cited: 21
Inés Califano, Anabella Smulever, Fernando Jerkovich, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 25, Iss. 1, pp. 123-147
Closed Access | Times Cited: 21
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network
Arnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
Thyroid (2023) Vol. 33, Iss. 10, pp. 1190-1200
Closed Access | Times Cited: 13
Arnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
Thyroid (2023) Vol. 33, Iss. 10, pp. 1190-1200
Closed Access | Times Cited: 13
Update on current diagnosis and management of anaplastic thyroid carcinoma
T. Pavlidis, I. Galanis, T. Pavlidis
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 12, pp. 570-583
Open Access | Times Cited: 12
T. Pavlidis, I. Galanis, T. Pavlidis
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 12, pp. 570-583
Open Access | Times Cited: 12
Construction of an anaplastic thyroid cancer stratification signature to guide immune therapy selection and validation of the pivotal gene HLF through in vitro experiments
Pengping Li, Kexin Yin, Xie Yuwei, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Pengping Li, Kexin Yin, Xie Yuwei, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Channel boosted convolutional neural network with segnet based segmentation for an automatic prediction of thyroid cancer
Leelavathi Arepalli, Venkata Rao Kasukiurthi, Madhavi Dabbiru
Soft Computing (2025)
Closed Access
Leelavathi Arepalli, Venkata Rao Kasukiurthi, Madhavi Dabbiru
Soft Computing (2025)
Closed Access
Evaluation of Treatment Response and Survival Outcomes in Anaplastic Thyroid Cancer Patients Following Surgery With and Without Other Treatment Modalities: A Systematic Review
Hossein Negahban, Nazila Heidari, Amirhossein Heidari, et al.
Health Science Reports (2025) Vol. 8, Iss. 5
Open Access
Hossein Negahban, Nazila Heidari, Amirhossein Heidari, et al.
Health Science Reports (2025) Vol. 8, Iss. 5
Open Access
Risk stratification in patients with anaplastic thyroid carcinoma: role of age
Mingjun Wang, Tao Wei, Rixiang Gong, et al.
Endocrine (2022) Vol. 77, Iss. 2, pp. 305-318
Closed Access | Times Cited: 12
Mingjun Wang, Tao Wei, Rixiang Gong, et al.
Endocrine (2022) Vol. 77, Iss. 2, pp. 305-318
Closed Access | Times Cited: 12
Diagnostic and Treatment Considerations for Thyroid Cancer in Women of Reproductive Age and the Perinatal Period
Evert F.S. van Velsen, Angela M. Leung, Tim I.M. Korevaar
Endocrinology and Metabolism Clinics of North America (2022) Vol. 51, Iss. 2, pp. 403-416
Open Access | Times Cited: 11
Evert F.S. van Velsen, Angela M. Leung, Tim I.M. Korevaar
Endocrinology and Metabolism Clinics of North America (2022) Vol. 51, Iss. 2, pp. 403-416
Open Access | Times Cited: 11
Evaluating new treatments for anaplastic thyroid cancer
Andrés Coca‐Pelaz, Juan P. Rodrigo, Fernando López, et al.
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 11, pp. 1239-1247
Closed Access | Times Cited: 11
Andrés Coca‐Pelaz, Juan P. Rodrigo, Fernando López, et al.
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 11, pp. 1239-1247
Closed Access | Times Cited: 11
Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study
Dmytro Oliinyk, Teresa Augustin, Josefine Rauch, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 3527-3547
Open Access | Times Cited: 11
Dmytro Oliinyk, Teresa Augustin, Josefine Rauch, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 3527-3547
Open Access | Times Cited: 11
The prevalence of DNA microsatellite instability in anaplastic thyroid carcinoma – systematic review and discussion of current therapeutic options
Maria Linda Rocha, Kurt Werner Schmid, Piotr Czapiewski
Współczesna Onkologia (2021) Vol. 25, Iss. 3, pp. 213-223
Open Access | Times Cited: 13
Maria Linda Rocha, Kurt Werner Schmid, Piotr Czapiewski
Współczesna Onkologia (2021) Vol. 25, Iss. 3, pp. 213-223
Open Access | Times Cited: 13
Primary Versus Secondary Anaplastic Thyroid Carcinoma: Perspectives from Multi-institutional and Population-Level Data
Tam N.M. Ngo, Trang Thi Bich Le, Thoa Le, et al.
Endocrine Pathology (2021) Vol. 32, Iss. 4, pp. 489-500
Closed Access | Times Cited: 11
Tam N.M. Ngo, Trang Thi Bich Le, Thoa Le, et al.
Endocrine Pathology (2021) Vol. 32, Iss. 4, pp. 489-500
Closed Access | Times Cited: 11
Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer
Anja C. Mortensen, Hanna Berglund, Mehran Hariri, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Anja C. Mortensen, Hanna Berglund, Mehran Hariri, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Anaplastic thyroid cancer:Improved understanding of what remains a deadly disease
Eoin F. Cleere, Sarah Prunty, James P. O’Neill
The Surgeon (2023) Vol. 22, Iss. 1, pp. e48-e53
Closed Access | Times Cited: 4
Eoin F. Cleere, Sarah Prunty, James P. O’Neill
The Surgeon (2023) Vol. 22, Iss. 1, pp. e48-e53
Closed Access | Times Cited: 4
Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer
Kazumasa Sekihara, Hidetomo Himuro, Soji Toda, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1286-1286
Open Access | Times Cited: 1
Kazumasa Sekihara, Hidetomo Himuro, Soji Toda, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1286-1286
Open Access | Times Cited: 1
Survival in Thyroid Cancer in Sweden From 1999 To 2018
Frantisek Zitricky, Anni Koskinen, Kristina Sundquist, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 659-671
Open Access | Times Cited: 1
Frantisek Zitricky, Anni Koskinen, Kristina Sundquist, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 659-671
Open Access | Times Cited: 1
Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation
Rubai Ahmed, Sovan Samanta, Jhimli Banerjee, et al.
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100131-100131
Open Access | Times Cited: 6
Rubai Ahmed, Sovan Samanta, Jhimli Banerjee, et al.
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100131-100131
Open Access | Times Cited: 6
Current Application of Nanoparticle Drug Delivery Systems to the Treatment of Anaplastic Thyroid Carcinomas
Chonggao Wang, Yewei Zhang
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 6037-6058
Open Access | Times Cited: 3
Chonggao Wang, Yewei Zhang
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 6037-6058
Open Access | Times Cited: 3
Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas
Anja C. Mortensen, Juliana Imgenberg‐Kreuz, Diana Spiegelberg, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22594-e22594
Open Access | Times Cited: 2
Anja C. Mortensen, Juliana Imgenberg‐Kreuz, Diana Spiegelberg, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22594-e22594
Open Access | Times Cited: 2
Clinical Outcome and Toxicity in the Treatment of Anaplastic Thyroid Cancer in Elderly Patients
Teresa Augustin, Dmytro Oliinyk, Viktoria Florentine Koehler, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3231-3231
Open Access | Times Cited: 4
Teresa Augustin, Dmytro Oliinyk, Viktoria Florentine Koehler, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3231-3231
Open Access | Times Cited: 4
Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?
C. Christofer Juhlin
Cancer Drug Resistance (2020)
Open Access | Times Cited: 4
C. Christofer Juhlin
Cancer Drug Resistance (2020)
Open Access | Times Cited: 4
Complete pathological response following chemotherapy and radiotherapy in two cases of advanced anaplastic thyroid carcinoma
Benjamin Chevalier, Oriane Karleskind, Arnaud Jannin, et al.
European Thyroid Journal (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Benjamin Chevalier, Oriane Karleskind, Arnaud Jannin, et al.
European Thyroid Journal (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 3
A novel mutation in PTEN in anaplastic thyroid carcinoma: A case report
Yanli Zhao
Biomedical Reports (2024) Vol. 21, Iss. 2
Open Access
Yanli Zhao
Biomedical Reports (2024) Vol. 21, Iss. 2
Open Access
Development and validation of survival nomograms for patients with anaplastic thyroid carcinoma: a SEER Program-based study
Chen Xinming, Pingwu Zhao, Yunsheng He, et al.
Research Square (Research Square) (2024)
Open Access
Chen Xinming, Pingwu Zhao, Yunsheng He, et al.
Research Square (Research Square) (2024)
Open Access
